Genome-wide association studies in atherosclerosis

Current Atherosclerosis Reports

Volumn 13, Issue 3, 2011, Pages 225-232

  Sivapalaratnam, S ^a   Motazacker, M M ^a   Maiwald, S ^a   Hovingh, G K ^a   Kastelein, J J P ^a   Levi, M ^a   Trip, M D ^a   Dallinga Thie, G M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; CVD; GWAS

Indexed keywords

5' METHYLTHIOADENOSINE PHOSPHORYLASE; ADAPTOR PROTEIN; CADHERIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; INSULIN RECEPTOR SUBSTRATE 1; KEXIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATASE AND ACTIN REGULATOR 1 PROTEIN; RAS PROTEIN; REGULATOR PROTEIN; SORTILIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ARTERY CALCIFICATION; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; NONHUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; CORONARY ARTERY DISEASE; GENE EXPRESSION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HOMEOSTASIS; HUMANS; LIPID METABOLISM; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79955884571     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-011-0173-4     Document Type: Review

References (62)

1. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa heart study. N Engl J Med. 1998;338:1650-6. (Pubitemid 28267909)
2. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041-6. (Pubitemid 24106561)
3. Sivapalaratnam S, Boekholdt SM, Trip MD et al. Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study. Heart 2010
4. Aouizerat BE, Allayee H, Cantor RM, et al. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11. Am J Hum Genet. 1999;65:397-412. (Pubitemid 30462997)
5. Wang L, Fan C, Topol SE, et al. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science. 2003;302:1578-81. (Pubitemid 37475704)
6. Wang Q, Rao S, Topol EJ. Miscues on the "lack of MEF2A mutations" in coronary artery disease. J Clin Invest. 2005;115:1399-400.
7. Guella I, Rimoldi V, Asselta R, et al. Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease. Circ Cardiovasc Genet. 2009;2:165-72.
8. Lieb W, Mayer B, Konig IR, et al. Lack of association between the MEF2A gene and myocardial infarction. Circulation. 2008;117:185-91.
9. Mani A, Radhakrishnan J, Wang H, et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science. 2007;315:1278-82. (Pubitemid 46364265)
10. Sarzani R, Salvi F, Bordicchia M et al. Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptorrelated protein 6 gene variant. Nutr Metab Cardiovasc Dis. 2009
11. Tomaszewski M, Charchar FJ, Barnes T, et al. A common variant in low-density lipoprotein receptor-related protein 6 gene (LRP6) is associated with LDL-cholesterol. Arterioscler Thromb Vasc Biol. 2009;29:1316-21.
12. Crosslin DR, Shah SH, Nelson SC, et al. Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis. Hum Genet. 2009;125:217-29.
13. Shen GQ, Li L, Girelli D, et al. An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. Am J Hum Genet. 2007;81:780-91. (Pubitemid 47596545)
14. Lanktree MB, Dichgans M, Hegele RA. Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke. 2010;41:825-32.
15. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166-76.
16. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002;296:2225-9. (Pubitemid 34680308)
17. Keating BJ, Tischfield S, Murray SS, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE. 2008;3:e3583.
18. Musunuru K and Kathiresan S. Genetics of coronary artery disease. Annu. Rev. Genomics Hum. Genet. 2010, 11: 91-108. This is an excellent review on the current status of genetic studies with CVD as the endpoint.
19. Schunkert H, Erdmann J, Samani NJ. Genetics of myocardial infarction: a progress report. Eur Heart J. 2010;31:918-25.
20. Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466: 707-13. This article uses a combination of GWA study metaanalyses and gene expression data to proof the importance of novel candidate genes for lipid metabolism. A novel gene, GALNT2, has been described in more detial in a novel mouse model.
21. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488-91. (Pubitemid 46906617)
22. Samani NJ, Schunkert H. Chromosome 9p21 and cardiovascular disease: the story unfolds. Circ Cardiovasc Genet. 2008;1:81-4.
23. Kathiresan S, Voight BF, Purcell S et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009
24. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443-53. (Pubitemid 47204873)
25. Samani NJ, Deloukas P, Erdmann J, et al. Large scale association analysis of novel genetic loci for coronary artery disease. Arterioscler Thromb Vasc Biol. 2009;29:774-80.
26. Musunuru K, Post WS, Herzog W, et al. Association of single nucleotide polymorphisms on chromosome 9p21.3 with platelet reactivity: a potential mechanism for increased vascular disease. Circ Cardiovasc Genet. 2010;3:445-53.
27. Bjorck HM, Lanne T, Alehagen U, et al. Association of genetic variation on chromosome 9p21.3 and arterial stiffness. J Intern Med. 2009;265:373-81.
28. Cunnington MS, Santibanez KM, Mayosi BM, et al. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet. 2010;6:e1000899.
29. Helgadottir A, Thorleifsson G, Magnusson KP, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008;40:217-24. (Pubitemid 351171400)
30. Folkersen L, Kyriakou T, Goel A, et al. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS ONE. 2009;4:e7677.
31. McPherson R. Chromosome 9p21 and coronary artery disease. N Engl J Med. 2010;362:1736-7.
32. Visel A, Zhu Y, May D, et al. Targeted deletion of the 9p21 noncoding coronary artery disease risk interval in mice. Nature. 2010;464:409-12.
33. Jarinova O, Stewart AF, Roberts R, et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol. 2009;29:1671-7.
34. Musunuru K, Strong A, Frank-Kamenetsky M et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010, 466: 714-19. This article describes the approach to identify a GWA signal and translate it into a functional mechanism using mouse models, in vitro studies, and also large cohorts to identify the QTL signal.
35. Kjolby M, Andersen OM, Breiderhoff T, et al. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab. 2010;12:213-23.
36. Goldstein JL, Sobhani MK, Faust JR, Brown MS. Heterozygous familial hypercholesterolemia: failure of normal allele to compensate for mutant allele at a regulated genetic locus. Cell. 1976;9:195-203.
37. Kotowski IK, Pertsemlidis A, Luke A, et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet. 2006;78:410-22. (Pubitemid 43291224)
38. Huijgen R, Vissers MN, Defesche JC, et al. Familial hypercholesterolemia: current treatment and advances in management. Expert Rev Cardiovasc Ther. 2008;6:567-81.
39. van Aalst-Cohen ES, Jansen AC, Tanck MW, et al. Diagnosing familial hypercholesterolaemia: the relevance of genetic testing. Eur Heart J. 2006;27:2240-6. (Pubitemid 44412840)
40. Stone NJ, Levy RI, Fredrickson DS, Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation. 1974;49:476-88.
41. Tregouet DA, Konig IR, Erdmann J, et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet. 2009;41:283-5.
42. Kamstrup PR. Lipoprotein(a) and ischemic heart disease - a causal association? A review. Atherosclerosis. 2010;211:15-23.
43. Utermann G. Genetic architecture and evolution of the lipoprotein (a) trait. Curr Opin Lipidol. 1999;10:133-41. (Pubitemid 29187096)
44. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009;301:2331-9.
45. Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361:2518-28.
46. Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol. 2008;28:1897-908.
47. Gleissner CA, von Hundelshausen P, Ley K. Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol. 2008;28:1920-7.
48. Zernecke A, Bot I, Djalali-Talab Y, et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res. 2008;102:209-17. (Pubitemid 351651125)
49. van Gils JM, da Costa Martins PA, Mol A, et al. Transendothelial migration drives dissociation of plateletmonocyte complexes. Thromb Haemost. 2008;100:271-9.
50. Erdmann J, Grosshennig A, Braund PS, et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet. 2009;41:280-2.
51. Nunez RN, Lee IN, Banno A, et al. Characterization of R-ras3/m-ras null mice reveals a potential role in trophic factor signaling. Mol Cell Biol. 2006;26:7145-54. (Pubitemid 44477691)
52. Folkersen L, van't Hooft F, Chernogubova E, et al. Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet. 2010;3:365-73.
53. Allen PB, Greenfield AT, Svenningsson P, et al. Phactrs 1-4: a family of protein phosphatase 1 and actin regulatory proteins. Proc Natl Acad Sci USA. 2004;101:7187-92. (Pubitemid 38596464)
54. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med. 2001;345:971-80.
55. Armendariz AD, Krauss RM. Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis. Curr Opin Lipidol. 2009;20:106-11.
56. Prudente S, Morini E, Trischitta V. Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. Nat Rev Endocrinol. 2009;5:682-93.
57. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet. 2009;41:342-7.
58. Tsai CT, Lai LP, Hwang JJ, et al. Molecular genetics of atrial fibrillation. J Am Coll Cardiol. 2008;52:241-50.
59. Paynter NP, Chasman DI, Buring JE, et al. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med. 2009;150:65-72.
60. Talmud PJ, Cooper JA, Palmen J, et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem. 2008;54:467-74. (Pubitemid 351348157)
61. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-53.
62. Vissers LE, de Ligt J, Gilissen C, et al. A de novo paradigm for mental retardation. Nat Genet. 2010;42:1109-12.